US
US,"
regulator
regulators
regulators,
recommend
research
reintroduction
reports.
really
rule
ruled
rung
risk
risks.
to
told
the
they
there
therapies".
that
than
three
though
things
this
tumbled
taking
take
time,
on
of
other
observed
oversee
or
pain
painkillers
painkillers.
panel
patients
profits
problems
products,
presented
people
possible
place.
drug
drug,
drugs
decide
developed
deaths.
days.
dollars
doubled
doesn't
doctors
disease
disease.
food
for
fourth-quarter
from
firm's
fewer
factors
a
and
any
analysts
announcement
at
attack
advisory
after
are
as
asked
aside
approval.
appear
also
alternative
already
available
about
will
with
withdrawn
withdrew
whether
who
which
was
would
were
went
Friday
Food
FDA
FDA's
Facing
sale
sales
said
said.
say
safety
stroke
stroke.
stopped
stomach
still
stem
sold
such
suggested
surprise.
shops
showed
should
shelves
shares
selling
set
slide
since
similar
have
has
had
harmful
handling
high
heart
heart.
hearing
head
been
benefits
bells
because
brand
but
back
battles
boost
body
by
linked
likely
litigation.
light
last
legal
least
The
Thursday
Thursday,
Tuesday
Dr
Drug
David
Administration
Alarm
Approve
According
American
Agency
(FDA)
(Â£581m),
give
giving
gets
it
its
inhibitors
inhibitors.
increased
including
injured
investigations
information
information,
independent
if
is
verdict
voluntarily
evidence
easier
earnings
earlier.
explained.
-
called
calculations
cause
caused
caught
cardiovascular
case,
consider
company
companies,
cover
cost
claim
class
clear
changed
criticism
create
COX-2
Celebrex
Cox-2
Cox-2"
under
unique
us
users
names
new
news
need
not
note
Vioxx
Vioxx.
Vioxx-related
year
Merck
Merck's
Medicines
Mr
justify
Putting
Pfizer
Pfizer,
Peter
make
makes
may
market
marketed
many
move
more
months.
millions
meanwhile,
30
September,
Senate
Safety
$1.1bn
$1.4bn
10%
18
Bextra
Kim
"based
"Given
"there
"cautious"
knowing
He
On
Office
Graham
November,
56,000
European